Dementia Diagnosis Reduced End-of-Life Treatment Support

Adults were 19 percentage points less likely to suggest life-sustaining care for dementia patients in recent survey data.

Updated on Oct. 7, 2026 in Alzheimer’s

Gouache-painted illustration of an empty, blank medical wristband on a clean white surface, symbolizing end-of-life care decision-making.
A University of Colorado Anschutz study found that a dementia diagnosis significantly reduces the likelihood that surrogates will recommend life-sustaining treatment for patients. AI Illustration. Upload story photo >

Live Poll

Do you trust that your advance directive will ensure your medical wishes are followed?

A new survey of 6,000 U.S. adults found that people were significantly less likely to recommend life-sustaining treatments for patients living with dementia compared to those without the condition. These findings highlight how a dementia diagnosis influences the medical choices made by surrogates on behalf of patients who can no longer communicate their own preferences.

Why it matters

Understanding how a dementia diagnosis skews end-of-life care decisions is critical for ensuring that patients receive the care they actually want. Because surrogate decision-making relies on human interpretation, awareness of these biases may help families and clinicians better align actions with patient values.

This randomized survey experiment published in JAMA Network Open involved 6,000 U.S. adults. Participants were 19 percentage points less likely to recommend life-sustaining treatment for patients with dementia compared to those without, regardless of advance directive status.

The players

University of Colorado Anschutz

A major academic medical center and research institution known for clinical studies and health policy analysis.

The details

Researchers at the University of Colorado Anschutz evaluated surrogate decision-making by asking participants to review hypothetical scenarios involving seriously ill hospitalized older adults. The experiment varied key factors including the patient's dementia status, the presence of written advance directives, and physician treatment recommendations. By comparing these variables, the researchers determined that dementia status alone influenced the likelihood of recommending life-sustaining interventions.

Timeline

  1. October 7, 2026: Researchers at the University of Colorado Anschutz published the study findings.

Health Landscape

This research highlights how surrogate interpretations can complicate the Patient Self-Determination Act, which aims to ensure patients' end-of-life wishes are respected. It illustrates a persistent gap between documented legal preferences and the actual care recommendations provided by human surrogates.

This finding underscores the importance of having clear, specific conversations with your designated healthcare proxy about your personal end-of-life wishes. It is worth discussing with your doctor how to ensure your documented preferences remain the primary guide for care regardless of potential future cognitive decline.

The takeaway

Cognitive status can significantly bias how others perceive your medical needs at the end of life. To safeguard your choices, ensure your advance directives are current and explicitly clarify your preferences for life-sustaining care with your family and physician.

Further reading

For more on managing care preferences, explore our comprehensive section on Alzheimer’s.

More information

Review the complete findings in the JAMA Network Open study article.

Source note: This article includes information reported by News-Medical.

Live Poll

Do you trust that your advance directive will ensure your medical wishes are followed?